Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details)

Basis of Presentation and Summary of Significant Accounting Policies - Restructuring Charges (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended	12 Months Ended
	Dec. 31, 2023	Sep. 30, 2022	Dec. 31, 2023	Jun. 30, 2023	Jun. 30, 2023
Restructuring costs	$ 11,424		$ 11,424
Cash payments	(1,434)
Non-cash adjustments	(6,229)
Accrued restructuring actions balances	3,761		3,761
Corporate
Restructuring costs			1,225
Diagnostics and Genomics
Restructuring costs			739
Protein Sciences
Restructuring costs			9,460
Protein Sciences \| QT Holdings Corporation
Restructuring costs		$ 2,170
Cash payments				$ (2,005)
Adjustments				(165)
Cost of Sales
Restructuring costs	1,174		1,174
Selling, General and Administrative Expenses
Restructuring costs	10,250		10,250
Selling, General and Administrative Expenses \| Protein Sciences \| QT Holdings Corporation
Restructuring costs					$ 2,170
Employee severance
Restructuring costs	4,882		4,882
Cash payments	(1,257)
Accrued restructuring actions balances	3,625		3,625
Employee severance \| Corporate
Restructuring costs			1,193
Employee severance \| Diagnostics and Genomics
Restructuring costs			739
Employee severance \| Protein Sciences
Accrued restructuring actions balances	195		897
Restructuring costs			2,950		1,677
Cash payments			(923)		(762)
Adjustments			221		18
Accrued restructuring actions balances				897	897
Employee severance \| Protein Sciences \| QT Holdings Corporation
Restructuring costs		1,328
Cash payments				(1,233)
Adjustments				(95)
Employee severance \| Selling, General and Administrative Expenses \| Protein Sciences \| QT Holdings Corporation
Restructuring costs					1,328
Asset-related and other
Restructuring costs	504		504
Cash payments	(177)
Non-cash adjustments	(191)
Accrued restructuring actions balances	136		136
Asset-related and other \| Corporate
Restructuring costs			32
Asset-related and other \| Protein Sciences
Restructuring costs			472
Impairment of assets held-for-sale
Restructuring costs	6,038		6,038
Non-cash adjustments	$ (6,038)
Impairment of assets held-for-sale \| Protein Sciences
Restructuring costs			$ 6,038
Asset impairment and other \| Protein Sciences \| QT Holdings Corporation
Restructuring costs		$ 842
Cash payments				(772)
Adjustments				$ (70)
Asset impairment and other \| Selling, General and Administrative Expenses \| Protein Sciences \| QT Holdings Corporation
Restructuring costs					$ 842